Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Posted on by ScienceFather

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi , Albany Medical college, United States

Mouloud Farrokhi is an experienced immunologist and microbiologist specializing in HIV/AIDS research, nanoparticle delivery systems, and viral infections. He is currently pursuing a PhD in Biology with a focus on Immunology and Microbiology at Albany Medical College, USA. Mouloud has a strong academic and professional background, having worked as a research assistant and medical laboratory scientist in Iran and Sweden. His research aims to improve understanding and treatment of viral infections, with significant contributions to HIV drug resistance and oncolytic virus therapy. Mouloud’s work also extends to the development of innovative nanoparticle-based drug delivery systems, offering promising solutions for invasive infections like Aspergillosis. His expertise spans from molecular biology to clinical research, with an emphasis on laboratory techniques like PCR, qRT-PCR, NGS, and CRISPR/Cas9.

Professional Profile:

Google Scholar

Mouloud Farrokhi: A Strong Contender for the Research Best Researcher Award

Mouloud Farrokhi is an exceptional candidate for the Research Best Researcher Award due to his extensive background in immunology, microbiology, and viral infections, as well as his significant contributions to molecular diagnostics and therapeutic innovations. His educational qualifications, research experience, and recognition in the field of medical sciences make him a highly suitable candidate for this prestigious award.

🎓Education:

Mouloud Farrokhi is currently pursuing a PhD in Biology, specializing in Immunology and Microbiology at Albany Medical College, USA (2023–Present). He holds two Master’s degrees: an MSc in Bioscience from the University of Skövde, Sweden (2021–2022), with a thesis on the role of RABL6 in AP3-dependent trafficking, and an MSc in Cellular and Molecular Biology from the Islamic Azad University, Iran (2010–2014), where he researched HIV-1 drug resistance. His undergraduate studies were in Marine Biology at the Islamic Azad University, Tehran, Iran (2003–2008). Mouloud’s extensive education in biological sciences provides a solid foundation for his current research endeavors, focusing on viral infections, molecular diagnostics, and therapeutic innovations.

🏢Experience:

Mouloud Farrokhi has gained extensive experience as a research assistant and medical laboratory scientist. He worked as a Research Assistant at Tehran University of Medical Sciences (2022–2023), where he focused on statistical analysis and NGS (Next Generation Sequencing). He has also served as a Medical Laboratory Assistant at Tehran University of Medical Sciences (2018–2021), where he conducted HIV viral load analysis and COVID-19 testing via qPCR. His previous roles include being a Medical Laboratory Scientist at Dena Lab (2017–2018), where he performed NITP tests and a Research Assistant at Pasteur Institute of Iran (2016–2017), where he researched drug resistance in HIV and HCV. He has also contributed to laboratory work at Keyvan Virology Laboratory, Tehran (2015–2016). Mouloud’s diverse hands-on experience makes him proficient in molecular biology techniques, data analysis, and lab management.

🏅Awards and Honors:

Mouloud Farrokhi’s academic and research achievements are reflected in his high academic standing and contributions to scientific research. His thesis at the University of Skövde received top marks, with a GPA of 3.75, and he has consistently demonstrated excellence throughout his academic career. His research contributions have been recognized in various publications and presentations. Notably, he presented at the International Student Congress in Medical Sciences (ISCOM) in 2017 and at the Upstate New York Immunology Conference (NYIC) in 2024. Mouloud’s work in HIV drug resistance and nanoparticle drug delivery systems has been published in high-impact journals. His dedication to advancing medical science has led to multiple research opportunities, including participation in workshops on gene transfer and vaccine design.

🔬Research Focus:

Mouloud Farrokhi’s research focuses on immunology, microbiology, and the molecular mechanisms underlying viral infections and drug resistance. He investigates the molecular pathways of HIV and other viral infections, focusing on drug resistance mechanisms in HIV-1 and HCV. His research also explores innovative strategies for oncolytic virus therapy and nanoparticle-based drug delivery, with the goal of improving treatment outcomes for invasive infections like Aspergillosis. Additionally, he is involved in genetic analysis and genomic editing technologies such as CRISPR/Cas9. Mouloud’s work integrates molecular diagnostics and therapeutic advancements, contributing significantly to both basic science and clinical applications in virology and immunology.

Publication Top Notes:

  • “Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013”
    • Citations: 31
  • “HIV drug resistance among naïve HIV-infected patients in Iran”
    • Citations: 14
  • “Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran”
    • Citations: 11
  • “The first characterization of HIV-1 subtypes and drug resistance mutations among antiretrovirally treated patients in Kermanshah, Iran”
    • Citations: 9
  • “HIV drug resistance and phylogeny profile in naive and antiretroviral-experienced patients in Tehran, Iran”
    • Citations: 8

 

 

 

Prof. Kang-Ho Choi | Nanotherapy Awards | Best Researcher Award

Posted on by ScienceFather

Prof. Kang-Ho Choi | Nanotherapy Awards | Best Researcher Award

Prof. Kang-Ho Choi, Chonnam National University Medical School and Hospital, South Korea

Dr. Kang-ho Choi is an esteemed Associate Professor in the Department of Neurology at Chonnam National University Hospital, Gwangju, Korea. He earned his M.D. from Chonnam National University Medical School in 2005, followed by a Ph.D. from the same institution in 2011. Dr. Choi completed extensive postgraduate training, including fellowships at Hanyang University Medical Center and Bristol University. His research and clinical expertise focus on neurology, with notable contributions in stroke and neurodegenerative diseases. Dr. Choi has received numerous awards for his research and clinical excellence, including multiple “Best Investigator” and “Best Poster Presentation” awards. He is a member of various professional organizations, including the Korean Neurological Association and the American Heart Association/American Stroke Association.

Professional Profile:

Scopus

Evaluation of Kangho Choi, M.D., Ph.D. for the Best Researcher Award

Summary of Suitability for Award:

Dr. Kangho Choi is a distinguished researcher in the field of neurology with an impressive track record of achievements that make him a highly suitable candidate for the Best Researcher Award

🎓Education:

Dr. Kang-ho Choi completed his medical education at Chonnam National University Medical School in Gwangju, Korea, where he earned his M.D. degree from March 1999 to February 2005. He continued his academic journey at Chonnam National University Graduate School, obtaining his Master’s degree (M.S.) from March 2006 to February 2008, and later his Ph.D. from March 2009 to February 2011.

🏢Work Experience:

Dr. Kang-ho Choi has held several key positions in his career. Since November 2016, he has been serving as an Associate Professor in the Department of Neurology at Chonnam National University Hospital in Gwangju, Korea. Prior to this role, he was an Assistant Professor in the same department from March 2011 to October 2016. Dr. Choi completed his Clinical Fellowship at Chonnam National University Hospital from March 2010 to February 2011, and also undertook Research Fellowships at Hanyang University Medical Center in Seoul, Korea, from November 2010 to December 2010, and at the School of Clinical Sciences, Bristol University in the United Kingdom, from March 2013 to June 2013. His foundational training includes a Residency in Neurology at Chonnam National University Hospital from March 2006 to February 2010 and a Medical Internship at the same institution from March 2005 to February 2006.

🏅Awards:

Dr. Kang-ho Choi has received numerous prestigious awards throughout his career, reflecting his significant contributions to neurology. He was honored with the Best Investigator Award from Chonnam National University Hospital in December 2019 and May 2022. Additionally, he received the Break-through of the Year award from KHIDI of Korea in December 2017 and from the NRF of Korea in December 2020. In July 2017, he earned the Young Investigator Award at the Hwasun Biomedical Workshop. Dr. Choi’s excellence in research presentations is highlighted by multiple Best Poster Presentation Awards, including those from the ICSU & ICAS Joint Conference in September 2016, the ICSU 2018 & 1st AKJSC Joint Conference in September 2018, Stroke Update 2023 & 11th JKJSC in November 2023, and APSC 2023 in December 2023. His accolades also include the Best Presentation Award at the 35th Conference of KNA in November 2016, the Best Article award at the Annual Meeting of the Korean Neurological Association in October 2009, and the Best Doctor of the Year award from Chonnam National University Hospital in February 2010. Earlier in his career, he was recognized as the Best Resident of the Year by The Korean Intern Resident Association in February 2007.

Publication Top Notes:

  • Focused Magnetic Stimulation for Motor Recovery After Stroke
  • Treatment of Ischemic Stroke by Atorvastatin-Loaded PEGylated Liposome
  • Secular Trends in Outcomes and Impact of Novel Oral Anticoagulants in Atrial Fibrillation-Related Acute Ischemic Stroke
  • Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry
  • Erratum: Corrigendum to “D-dimer to Fibrinogen Ratio Predicts Early Neurological Deterioration in Ischemic Stroke with Atrial Fibrillation”

 

 

 

Assoc Prof Dr. Chong Qiu | Nanomedicine Awards | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. Chong Qiu | Nanomedicine Awards | Young Scientist Award

Assoc Prof Dr. Chong Qiu, China Academy of Chinese Medical Sciences, China

Associate Professor Chong Qiu, Ph.D., is a prominent researcher at the Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing. He earned his bachelor’s and doctoral degrees from the School of Pharmaceutical Science, Peking University, in 2014 and 2019, respectively. Dr. Qiu’s research focuses on advanced nanocarriers for targeted drug delivery, including siRNA and protein delivery systems. He is an active Young Scientist Board Member for several journals and has published extensively, with notable papers in Nature Communications and Journal of Nanobiotechnology. His work has garnered significant attention and impact in the fields of nanomedicine and drug delivery.

Professional Profile:

Orcid

Suitability Summary for Young Scientist Award: Associate Professor Chong Qiu

Associate Professor Chong Qiu is an exemplary candidate for the Young Scientist Award. His pioneering research in nanocarriers for drug delivery, combined with his impressive publication record and leadership roles, highlights his exceptional potential and influence in the scientific community. His achievements and innovative contributions make him a standout nominee for this prestigious award

🎓Education:

Dr. Chong Qiu earned his Ph.D. in Pharmaceutical Sciences from the School of Pharmaceutical Science at Peking University, Beijing, China, in 2019. He completed his Bachelor’s Degree in Pharmaceutical Sciences at the same institution in 2014.

🏢Work Experience:

Dr. Chong Qiu has been serving as an Associate Professor at the Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, since 2019. In addition to his role at the Research Center, he is an ongoing Young Scientist Board Member for the Asian Journal of Pharmaceutical Sciences, iMeta, and Traditional Medicine Research and Exploration

🏅Awards and Recognition:

Dr. Chong Qiu has an extensive publication record in high-impact journals, including notable works in Nature Communications and the Journal of Nanobiotechnology. His research has garnered significant recognition and has made substantial contributions to the fields of nanomedicine and drug delivery.

Publication Top Notes:

  • Photoaffinity Probe-Based Antimalarial Target Identification of Artemisinin in the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
  • Enhanced Tumor Penetration Across the Blood-Brain Barrier: Endoplasmic Reticulum Membrane Hybrid siRNA Nanoplexes
  • Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
  • Advanced Strategies for Nucleic Acids and Small-Molecular Drugs in Combined Anticancer Therapy
  • Anemoside B4 Alleviates Neuropathic Pain Through Inhibiting Inflammation

 

 

 

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Posted on by ScienceFather

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Fernando Novio is an Associate Professor in the Chemistry Department at Universitat Autónoma de Barcelona (UAB). Born on May 5th, 1976, he holds a BSc in Chemistry (2000) and a Master’s degree (2002) from the University of Santiago de Compostela, and a Ph.D. in Chemistry from UAB (2007). His research expertise lies in the field of Inorganic Chemistry, with a focus on Bioinorganic and Nanomedicine. He has held postdoctoral positions at the Laboratoire de Chimie de Coordination in Toulouse and the Catalan Institute of Nanoscience and Nanotechnology (ICN2-CSIC). In December 2022, he secured a permanent position at UAB, where he leads a research group specializing in the development of nanostructured coordination polymers for therapeutic and diagnostic applications, particularly in brain diseases. Over his career, Novio has published 58 scientific papers, presented over 100 communications at conferences, and contributed to several European projects and patents. His work is widely recognized, with an h-index of 25 and approximately 1,400 citations. He has also been an editor of a scientific book and regularly reviews for prestigious journals.

Professional Profile:

Scopus

Google Scholar

Suitability Summary for Best Researcher Award:

Summary of Suitability: Dr. Fernando Novio is a highly qualified candidate for the Best Researcher Award, given his extensive academic background, research experience, and significant contributions to the fields of Inorganic Chemistry, Bioinorganic Chemistry, and Nanomedicine. His educational journey, beginning with a BSc in Chemistry (2000) and a Master’s degree (2002) from the University of Santiago de Compostela, culminated in a Ph.D. in Chemistry from Universitat Autónoma de Barcelona (UAB) in 2007. This strong foundation has enabled him to excel in his research career, particularly in developing coordination polymers for therapeutic and diagnostic applications, with a focus on brain diseases.

🎓Education:

Fernando Novio completed his BSc in Chemistry in 2000, followed by a Master’s degree in Chemistry in 2002, both from the University of Santiago de Compostela. He later pursued his Ph.D. in Chemistry at Universitat Autónoma de Barcelona (UAB), which he successfully completed in 2007.

🏢Work Experience:

After earning his Ph.D. in Chemistry, Fernando Novio undertook a postdoctoral position at the Laboratoire de Chimie de Coordination in Toulouse, France, where he worked from 2008 to 2011. He then continued his research as a postdoctoral researcher at the Catalan Institute of Nanoscience and Nanotechnology (ICN2-CSIC) in Barcelona, Spain, from 2011 to 2022. In December 2022, he was appointed as an Associate Professor in the Chemistry Department at Universitat Autónoma de Barcelona (UAB).

🏆Awards:

Fernando Novio has been honored with the Best Researcher Award at the International Research Awards, recognizing his significant contributions to the field. Additionally, he has received recognition for his work in Nanomedicine and Bioinorganic Chemistry, further highlighting his impact and achievements in these specialized areas of research.

Publication Top Notes:

  • Comparative study of frequency-dependent dielectric properties of ferrites MFe2O4 (M = Co, Mg, Cr and Mn) nanoparticles
    • Cited by: 58
  • NiFe2O4 nanoparticles/MWCNTs nanohybrid as anode material for lithium-ion battery
    • Cited by: 57
  • Nanohybrids of multi-walled carbon nanotubes and cobalt ferrite nanoparticles: High performance anode material for lithium-ion batteries
    • Cited by: 24
  • Nanocomposites of multi-walled carbon nanotubes/cobalt ferrite nanoparticles: synthesis, structural, dielectric and impedance spectroscopy
    • Cited by: 20
  • Annealing Induced Enhancement in Magnetic Properties of Co0.5Zn0.5Fe2O4 Nanoparticles
    • Cited by: 14

 

 

Prof. Dr. Vlasta Bonačić-Koutecky | Nanobiotechnology Award | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Vlasta Bonačić-Koutecky | Nanobiotechnology Award | Best Researcher Award

Prof. Dr. Vlasta Bonačić-Koutecky  , Humbolt University, ICAST University of Split , Germany

Vlasta Bonačić-Koutecký is a distinguished Professor at the Department of Chemistry, Humboldt University, Berlin. Since 2010, she has been instrumental in founding the Interdisciplinary Center for Advanced Science and Technology (ICAST) at the University of Split, Croatia, and assumed leadership of the Center of Excellence STIM in 2014. Her groundbreaking work in nanoscience focuses on metal nanoclusters, highlighting their unique structural, optical, and reactivity properties that blend molecular-like characteristics with metallic traits. This innovative approach has expanded the boundaries of traditional nanoscience, integrating small metal nanoclusters into materials science. Her research spans nanocatalysis for renewable energy, nano-optics, and nano-biosensing for medical diagnostics

Professional Profile:

Scopus

Orcid

Education:

Vlasta Bonačić-Koutecký earned her PhD in Chemistry from Humboldt University in Berlin. Her doctoral studies laid the foundation for her distinguished career in nanoscience, focusing particularly on the unique properties of metal nanoclusters. This academic journey at Humboldt University equipped her with the expertise to explore the structural, optical, and reactivity characteristics of these nanoclusters, which blend molecular-like features with metallic attributes. Her research has significantly advanced the field of nanoscience, particularly in integrating small metal nanoclusters into materials science for applications in nanocatalysis for renewable energy, nano-optics, and nano-biosensing for medical diagnostics

Work Experience:

Professor Vlasta Bonačić-Koutecký holds a prominent position at the Department of Chemistry, Humboldt University, Berlin, where she contributes significantly to the field of chemistry. Since 2010, she has also been instrumental in founding and directing the Interdisciplinary Center for Advanced Science and Technology (ICAST) at the University of Split in Croatia. Under her leadership, ICAST has fostered interdisciplinary research at the intersection of various scientific disciplines. In addition to her role at ICAST, Professor Bonačić-Koutecký has served as the head of the Center of Excellence STIM at the University of Split since 2014. This center focuses on achieving excellence in research and innovation, further solidifying her reputation as a leader in advancing scientific knowledge and interdisciplinary collaboration.

Research Focus:

Professor Vlasta Bonačić-Koutecký is a leading figure in nanoscience, specializing in metal nanoclusters. Her research focuses on unraveling the structural, optical, and reactivity properties of these nanoclusters, which exhibit a unique blend of molecular-like characteristics and metallic behavior. She has pioneered their application in diverse fields such as nanocatalysis for renewable energy, leveraging their catalytic efficiency, nano-optics for advanced optical materials, and nano-biosensing for precise medical diagnostics. Through her innovative approach, Professor Bonačić-Koutecký has expanded the frontiers of nanoscience, demonstrating the transformative potential of metal nanoclusters across interdisciplinary research and technological applications.

Publication Top Notes:

1. Ligand Impact on Reactive Oxygen Species Generation of Au10 and Au25 Nanoclusters upon One- and Two-Photon Excitation

  • Journal: Communications Chemistry
  • Publication Year: 2023
  • Volume: 6
  • Citations: 5

2. Excitation-Dependent Fluorescence with Excitation-Selective Circularly Polarized Luminescence from Hierarchically Organized Atomic Nanoclusters

  • Journal: ACS Nano
  • Publication Year: 2023
  • Volume: 17
  • Citations: 4

3. Model Systems for Dye-Sensitized Solar Cells: Cyanidin-Silver Nanocluster Hybrids at TiO2 Support

  • Journal: RSC Advances
  • Publication Year: 2023
  • Citations: 2

4. Engineering Liganded Gold Nanoclusters as Efficient Theranostic Agents for Cancer Applications

  • Journal: ChemBioChem
  • Publication Year: 2023
  • Citations: 6

5. Stability and Properties of New-Generation Metal and Metal-Oxide Clusters Down to Subnanometer Scale

  • Journal: Physical Chemistry Chemical Physics
  • Publication Year: 2023 (Article in Press)